{"abstract":"The Food and Drug Administration (FDA) is announcing the renewal of the Oncologic Drugs Advisory Committee by the Commissioner of Food and Drugs (the Commissioner). The Commissioner has determined that it is in the public interest to renew the Oncologic Drugs Advisory Committee for an additional 2 years beyond the charter expiration date. The new charter will be in effect until the September 1, 2028, expiration date.","action":"Notice; renewal of Federal advisory committee.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2026/08/21/2026-17084.html","cfr_references":[],"citation":"91 FR 54332","comment_url":null,"comments_close_on":null,"correction_of":null,"corrections":[],"dates":"Authority for the Oncologic Drugs Advisory Committee will expire on September 1, 2026, unless the Commissioner formally determines that renewal is in the public interest.","disposition_notes":null,"docket_ids":["Docket No. FDA-2026-N-0008"],"dockets":[{"supporting_documents":[],"agency_name":"FDA","documents":[{"comment_count":0,"comment_start_date":"2026-08-21","updated_at":"2026-08-21T09:57:24.993-04:00","comment_url":"https://www.regulations.gov/commenton/FDA-2026-N-0008-0012","allow_late_comments":false,"id":"FDA-2026-N-0008-0012","comment_end_date":null,"regulations_dot_gov_open_for_comment":false}],"supporting_documents_count":0,"id":"FDA-2026-N-0008","title":"Advisory Committee"}],"document_number":"2026-17084","effective_on":null,"end_page":54335,"executive_order_notes":null,"executive_order_number":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2026/08/21/2026-17084.xml","html_url":"https://www.federalregister.gov/documents/2026/08/21/2026-17084/advisory-committee-oncologic-drugs-advisory-committee-renewal","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2026-17084?publication_date=2026-08-21","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2026-08-21/2026-17084/mods.xml","not_received_for_publication":null,"page_length":4,"page_views":{"count":297,"last_updated":"2026-10-24 08:15:05 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-08-21/pdf/2026-17084.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-17084.pdf?1787229913","publication_date":"2026-08-21","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2026/08/21/2026-17084.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"supporting_documents":[],"comments_count":0,"agency_id":"FDA","comments_url":"https://www.regulations.gov/docketBrowser?rpp=50&so=DESC&sb=postedDate&po=0&dct=PS&D=FDA-2026-N-0008","supporting_documents_count":0,"docket_id":"FDA-2026-N-0008","document_id":"FDA-2026-N-0008-0012","regulation_id_number":null,"title":"Advisory Committee","checked_regulationsdotgov_at":"2026-08-22T16:55:05Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":54332,"subtype":null,"title":"Advisory Committee; Oncologic Drugs Advisory Committee; Renewal","toc_doc":"Oncologic Drugs Advisory Committee","toc_subject":"Charter Amendments, Establishments, Renewals and Terminations","topics":[],"type":"Notice","volume":91}